Synvisc-One® Knee Injection Recall
Little Rock Defective Product Attorney
Sanofi Genzyme has initiated an urgent recall of Synvisc-One®, an injected hyaluronic acid gel for treating arthritis in knees. If you were injected with one of the contaminated syringes, you may be entitled to a cash settlement.
At Rainwater, Holt & Sexton, we understand most patients aren’t sure which injections were used for their procedures.
Synvisc-One® Knee Injection Side Effects
Synvisc-One, which was approved by the FDA in 2009, generated nearly $410 million in sales last year. The injectable gel is used to provide relief for patients with arthritis. However, an ongoing investigation revealed the presence of harmful microbial contamination.
A lot containing 18,000 syringes of Synvisc-One tested positive for microbial contamination and has been linked to increased health risks and hospitalization. Patients suffering from contaminated syringes may experience any of the following symptoms:
- Knee pain
- Trouble walking
- Heat or redness
- Fluid build-up in or around the knee
These side effects can be painful and may require hospitalization for treatment, which can leave patients facing recovery periods that limit their ability to work and reduce their quality of life.
Get The Help You Deserve
Use of the recalled Synvisc-One knee injections poses serious health risks. If you or a loved one has suffered injuries due to Synvisc-One, our legal team at Rainwater, Holt & Sexton wants to help. We have made it our mission to fight for the rights of injury victims and their families, and we want to help you too.
Synvisc-One® is a registered trademark of Genzyme Corporation, a Sanofi Aventis U.S. company, and is used here only to identify the product in question.
This firm is not associated with, sponsored by, or affiliated with Genzyme Corporation, Sanofi Aventis U.S, or the U.S. Food and Drug Administration.